aid: novo-nordisk
name: Novo Nordisk
description: >-
  Novo Nordisk A/S is a Danish multinational pharmaceutical company
  headquartered in Bagsværd, Denmark, and the world leader in diabetes
  care. The company also develops treatments for obesity, rare blood
  disorders, and growth-hormone therapy, including its widely known
  GLP-1 medicines Ozempic, Wegovy, and Rybelsus. Novo Nordisk does not
  publish a public commercial developer API. The company maintains a
  research GitHub organization (novonordisk-research) that releases
  open-source scientific computing libraries and an SDK for the Waters
  Empower Web API (OptiHPLCHandler) used in pharmaceutical analytical
  chemistry workflows.
type: Index
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/apis-json-logo.jpg
tags:
  - Pharmaceutical
  - Healthcare
  - Biotechnology
  - Diabetes
  - Obesity
  - Open Source Research
url: >-
  https://raw.githubusercontent.com/api-evangelist/novo-nordisk/refs/heads/main/apis.yml
created: '2026-05-05'
modified: '2026-05-16'
specificationVersion: '0.19'
apis: []
common:
  - type: DomainSecurity
    url: security/novo-nordisk-domain-security.yml
  - type: LinkedIn
    url: https://www.linkedin.com/company/novo-nordisk
  - type: Website
    url: https://www.novonordisk.com/
  - type: GitHubOrganization
    url: https://github.com/novonordisk-research
  - type: PartnerPortal
    url: https://digitalpartnerships.novonordisk.com/
    description: Novo Nordisk Digital Partnerships portal — the public landing for would-be technology / data partners. No open APIs; partnership outreach only (the `developer.novonordisk.com` subdomain 301s here).
maintainers:
  - FN: Kin Lane
    email: kin@apievangelist.com